Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2019–2025 · program · P50
Development Research Program
Stephanie S Watowich · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Developmental Research Program
James C Yao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Project 2: Targeting STAT3 with an Oral Small Molecule to Treat HCC
David John Tweardy · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
Developmental Research Program
James C Yao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Career Enhancement Program
James C Yao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Core 1: Biobank and Pathology
Asif Rashid · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
Career Enhancement Program
James C Yao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
Shubham Pant · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
Development Research Program
Stephanie S Watowich · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Core 2: Biostatistics and Bioinformatics Core
Ying Yuan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Core 2: Biostatistics and Bioinformatics
Peng Wei · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
Core 2: Biostatistics and Bioinformatics
Jeffrey S Morris · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
Career Enhancement Program
Jennifer A. Wargo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Career Enhancement Program
Scott Kopetz · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Project 1: Targeting the PD-1 pathway in HCC
Ahmed Kaseb · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
Michael Davies · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Project 1: Personalized Adjuvant Immunotherapy for High-risk Colorectal Cancer.
Michael J Overman · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Administrative Core
Scott Kopetz · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Administrative Core
Laura Beretta · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
Administrative Core
Laura Beretta · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
Core 3-Biostatistics
J. Jack Lee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Developmental Research Program
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
Core 1: Biospecimen and Pathology Core
Dipen M. Maru · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
miR-155 targeted therapeutics for precision medicine in lung cancer
George A. Calin · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Exploring Collateral Lethality for Development of Cancer Therapeutics
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2019 · research · R13
8th International Symposium on the Biology of Vertebrate Sex Determination
Richard R Behringer · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2022 · research · R01
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2028 · research · R35
Deciphering the hierarchical modularity of the mammalian cell through network integration and complex genetic perturbation strategies
Glen Traver Hart · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2021 · research · R21
Co-operative roles for YAP1 and UCHL5 in cancer progression and therapy
Kunal Rai · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
A phospho-switch in delta-catenin: relationship to PDZ-domain proteins and neuron development
Pierre D Mccrea · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2023 · career development · K08
Obstetrical and Oncological Outcomes Among Reproductive Age Women with Gynecological and Breast Cancer
Jose Alejandro Rauh-Hain · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2024 · research · R01
A Combination Therapy to Treat Cancer-Related Fatigue
Sriram Yennu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018 · grant · Academic Research
Targeting neutrophil elastase as a novel therapy for metastatic breast cancer
Stephanie Watowich · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2018–2021 · research · R21
Glucocorticoid Receptor degrading bifunctional molecules as therapeutics in prostate cancer
Yonathan Lissanu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Fuguo Jiang · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2018–2023 · training · T32
Translational Genomics and Precision Medicine in Cancer Training Program
Ann M Killary · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2021 · research · R00
MDSC-Tumor Crosstalk in Prostate Cancer Progression and Castration Resistance
Guocan Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2021 · contract · N01
RANK Ligand Inhibition - a Potential Chemoprevention Strategy for Women at High Genetic Risk of Breast Cancer HHSN2612015000181 TO: HHSN26100009 PP: 9/17/18 to 3/16/2021
Powel Brown · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2021 · research · R21
Collateral Deletions Expose Targetable Metabolic Vulnerabilities in the PTEN locus
Florian Muller · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2018–2021 · research · R21
Mechanisms of Alcohol Initiation of Chronic Pancreatic Diseases
Raghu Kalluri · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
